Ehrich Elliot

Avg. Two Year Performance

No purchase track record
(53%) Avg. Sale Return
(24%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(2%)(8%)(17%)(32%)(53%)
Sale Success Rate16 of 3511 of 3511 of 358 of 3512 of 35
Drugs » Drug Delivery

SVP, R&D & Chief Medical Ofcr:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Drug Delivery

EVP, R&D & CMO, Alkermes, Inc.:

Holdings: 57.06K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--